Jci_page_head_homepage_01 Jci_page_head_homepage_02
Mirjam van der Burg, Lieneke R. van Veelen, Nicole S. Verkaik, Wouter W. Wiegant, Nico G. Hartwig, Barbara H. Barendregt, Linda Brugmans, Anja Raams, Nicolaas G.J. Jaspers, Malgorzata Z. Zdzienicka, Jacques J.M. van Dongen, Dik C. van Gent
Published in Volume 116, Issue 1
J Clin Invest. 2006; 116(1):137–145 doi:10.1172/JCI26121
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2
IRIF formation in patient SC2 fibroblasts.

(A) WT primary human fibroblasts and patient SC2 primary fibroblasts were untreated or γ irradiated with increasing doses (1, 2, 4, 6, 8, 10, and 12 Gy) and fixed after an incubation period of 8 hours followed by immunostaining with the MRE11 or γ-H2AX antibodies. (B) Kinetics of loss of γ-H2AX foci in fibroblasts derived from patient SC2 and the LIG4-defective patients 180BR (a radiosensitive leukemia patient) and 411BR (a patient with the LIG4 syndrome), and WT FN1 cells, following x-ray irradiation (1 Gy). The number of foci per nucleus was determined in 40 cells at the indicated times after irradiation.